Texas Capital Bancshares Inc
TCBIO- Exchange
- Nasdaq
- Industry
- State Commercial Banks
- SEC CIK
- 0001077428
In the last 90 days, Texas Capital Bancshares Inc insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesTCBI
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $204.6K in total
- 1
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding TCBIO, Q2 2026
No superinvestor reported holding TCBIO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Texas Capital Bancshares Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 (view filing)4:32 PM ET | Jul 24 | 3 days | Detrich EllenController | SSale | −2.04K | $100.03 | −$204.6K | −21.4%7.53K after | |
| Jun 16, 2026 (view filing) | Jun 15 | 1 day | Scurlock John MatthewChief Financial Officer | PPurchase | +43.91 | $101.29 | +$4.45K | +0.2%22.3K after | |
| Jun 10, 2026 (view filing) | Jun 9 | 1 day | Alvarado Anna MChief Legal Officer | SSale | −3.50K | $100.95 | −$353.3K | −12.8%23.8K after | |
| Jun 8, 2026 (view filing) | Jun 5-8 | 3 days | Holmes Rob CChairman, President and CEO | SSale | −98.6K | $101.55 | −$10.0M | −37.0%167.6K after | 2 lots |
| Mar 12, 2026 (view filing) | Mar 11 | 1 day | Arbour Paola MDirector | PPurchase | +1.00K | $91.50 | +$91.5K | +17.6%6.67K after | |
| Mar 9, 2026 (view filing) | Mar 5-6 | 4 days | Stallings Robert WDirector | PPurchaseDepositary Shares for Series B Preferred Stock | +25.5K | $22.71 | +$579.2K | +17.0%175.1K after | 2 lots |
| Mar 5, 2026 (view filing) | Mar 3-4 | 2 days | Stallings Robert WDirector | PPurchaseDepositary Shares for Series B Preferred Stock | +45.0K | $22.24 | +$1.00M | +43.0%149.6K after | 2 lots |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Stallings Robert WDirector | PPurchase | +3.33K | $94.86 | +$315.9K | +1.1%293.3K after | |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Stallings Robert WDirector | PPurchaseDepositary Shares for Series B Preferred Stock | +5.00K | $22.29 | +$111.5K | +1.4%360.9K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Stallings Robert WDirector | PPurchaseDepositary Shares for Series B Preferred Stock | +20.0K | $22.22 | +$444.4K | +23.6%104.6K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Texas Capital Bancshares Inc at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding TCBIO in 13F filings for Q2 2026.